These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6166035)

  • 21. H1-antihistamines and calmodulin antagonists inhibit the ionophore A23187-induced eicosanoid formation by human leukocytes.
    Simmet T; Luck W
    Agents Actions; 1989 Mar; 26(3-4):273-8. PubMed ID: 2567567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A; Coutts S; Weinryb I
    Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxatomide: in vivo assessment of antagonistic activity, and effects on histamine release and enzymatic histamine degradation in skin.
    Gatti S; Coutts A; Francis D; Greaves MW
    Br J Dermatol; 1980 Dec; 103(6):671-7. PubMed ID: 6161634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
    Okayama Y; Benyon RC; Lowman MA; Church MK
    Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of oxatomide on oxygen-radical generation and peptide-leukotriene release from guinea pig eosinophils.
    Ohmori K; Manabe H; Akuta-Ohnuma K
    Arzneimittelforschung; 1998 Jan; 48(1):43-6. PubMed ID: 9522030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of ketotifen-induced histamine release from human peripheral leucocytes.
    Moodley I; Davies RJ
    Int Arch Allergy Appl Immunol; 1982; 68(2):176-8. PubMed ID: 6176557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413.
    Nishimura N; Ito K; Tomioka H; Yoshida S
    Immunopharmacol Immunotoxicol; 1987; 9(4):511-21. PubMed ID: 2449488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tiaramide derivative, 5-chloro-3-(4-hydroxypiperadinocarbonylmethyl)benzothiazoline-2-one (HPR-611), a potent inhibitor of anaphylactic chemical mediator release--a distinctive feature from disodium cromoglycate.
    Nabe T; Hashii H; Matsubara S; Yasui K; Yamamura H; Horiba M; Watanabe-Kohno S; Ohata K
    J Pharmacobiodyn; 1992 Dec; 15(12):673-9. PubMed ID: 1284281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological actions of oxatomide (KW-4354). 3. Actions on experimental asthma and Schultz-Dale reaction].
    Ohmori K; Ishii H; Takei Y; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):481-93. PubMed ID: 6131021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug prevention of bronchial asthma: inhibition of histamine and exercise-induced asthma by a new anti-anaphylactic oral preparation (ketotifen) (author's transl)].
    Wüthrich B; Radielovic P
    Dtsch Med Wochenschr; 1978 Nov; 103(47):1865-9. PubMed ID: 30613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the effects of ketotifen and clemastine on cutaneous and airway reactivity to histamine and allergen in atopic asthmatic subjects.
    Esau S; del Carpio J; Martin JG
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 1):270-4. PubMed ID: 6470361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiallergic effects of a novel compound, SWR-00151].
    Tanaka Y; Masai E; Yashima T; Furukawa M
    Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):193-206. PubMed ID: 9160349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of ketotifen and disodium cromoglycate in bronchial challenge tests with allergens (author's transl)].
    Klein G; Urbanek R; Matthys H; Hamm M
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1313-5. PubMed ID: 6780292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
    Okayama Y; Church MK
    Int Arch Allergy Immunol; 1992; 97(3):216-25. PubMed ID: 1375203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Aug; 69(4):663-7. PubMed ID: 6159940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen-induced increase in airway responsiveness is not inhibited by acute treatment with ketotifen or clemastine.
    Cockcroft DW; Keshmiri M; Murdock KY; Gore BC
    Ann Allergy; 1992 Mar; 68(3):245-50. PubMed ID: 1546820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.